Methyl 4-aminotetrahydro-2H-pyran-3-carboxylate is a heterocyclic organic compound featuring both an amino group and a methyl ester group on a tetrahydropyran ring scaffold. This specific substitution pattern makes it a valuable chiral building block in synthetic chemistry. Its primary application is as a key intermediate in the pharmaceutical industry. It serves as a crucial precursor in the synthesis of various drug candidates and active pharmaceutical ingredients (APIs). Notably, it is extensively used in the preparation of hepatitis C virus (HCV) protease inhibitors, such as Grazoprevir (MK-5172), where its structure forms part of the macrocyclic P2-P4 linker. The compound's chirality and functional groups allow for the construction of complex molecular architectures required for high biological activity. As a bifunctional synthon containing a protected amine and an ester, it is also employed in medicinal chemistry research for constructing diverse compound libraries. Its utility extends to the synthesis of other heterocyclic systems and as a starting material for further derivatization, highlighting its role beyond a single specific drug synthesis pathway.